Jinn Wu
Director/Board Member presso ATHENEXPAR
Profilo
Jinn Wu is the founder of XenoBiotic Laboratories, Inc. He is currently the Chairman at AiViva BioPharma, Inc. and AiViva Holding Ltd.
He is also an Independent Director at Athenex, Inc. In addition, he is a Member of the American Chemical Society, the American Association of Pharmaceutical Scientists, the International Society for the Study of Xenobiotics, and the American Society of Pharmacognosy.
Dr. Wu's former positions include being a Director at Enhance Biotech, Inc., Ardent Pharmaceuticals, Inc., and Handa Pharmaceuticals, Inc. He was also a Research Scientist at FMC Corp.
Furthermore, he was a Member-College of Pharmacy at The Ohio State University from 2007 to 2013 and served as the Chief Scientific Officer & Senior Vice President at Wuxi Apptec, Inc. from 2015 to 2016.
Dr. Wu obtained his doctorate degree from The Ohio State University.
Posizioni attive di Jinn Wu
| Società | Posizione | Inizio |
|---|---|---|
| ATHENEXPAR | Director/Board Member | 01/04/2007 |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
| International Society for the Study of Xenobiotics | Corporate Officer/Principal | - |
| American Society of Pharmacognosy | Corporate Officer/Principal | - |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
XenoBiotic Laboratories, Inc.
 XenoBiotic Laboratories, Inc. BiotechnologyHealth Technology Part of New Wuxi Life Science Holdings Ltd., XenoBiotic Laboratories, Inc. is a private company that provides bioanalytical, drug metabolism, and pharmacokinetic services. The company is based in Plainsboro, NJ. The company was founded by Jinn Wu. Jinn Wu has been the CEO since incorporation. XenoBiotic Laboratories was acquired by Wuxi PharmaTech (Cayman), Inc. on October 01, 2014. | Chief Executive Officer | 01/09/2017 |
Aiviva Biopharma, Inc.
 Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Chairman | 01/01/2016 |
AiViva Holding Ltd.
 AiViva Holding Ltd. Financial ConglomeratesFinance AiViva Holding Ltd. functions as an investment holding company. The company is based in Newport Beach, CA. The CEO of the company is Diane Tang-Liu. | Chairman | - |
Precedenti posizioni note di Jinn Wu
| Società | Posizione | Fine |
|---|---|---|
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| ░░░ ░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Jinn Wu
| The Ohio State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| FMC CORPORATION | Process Industries |
| HANDA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Enhance Biotech, Inc.
 Enhance Biotech, Inc. BiotechnologyHealth Technology Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY. | Health Technology |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Ardent Pharmaceuticals, Inc.
 Ardent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ardent Pharmaceuticals, Inc. researches and develops drugs for pain, urinary incontinence, premature ejaculation, depression and cardio protection. The company is headquartered in New York, NY. | Health Technology |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
| International Society for the Study of Xenobiotics | |
| American Society of Pharmacognosy | |
XenoBiotic Laboratories, Inc.
XenoBiotic Laboratories, Inc. BiotechnologyHealth Technology Part of New Wuxi Life Science Holdings Ltd., XenoBiotic Laboratories, Inc. is a private company that provides bioanalytical, drug metabolism, and pharmacokinetic services. The company is based in Plainsboro, NJ. The company was founded by Jinn Wu. Jinn Wu has been the CEO since incorporation. XenoBiotic Laboratories was acquired by Wuxi PharmaTech (Cayman), Inc. on October 01, 2014. | Health Technology |
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Health Technology |
AiViva Holding Ltd.
AiViva Holding Ltd. Financial ConglomeratesFinance AiViva Holding Ltd. functions as an investment holding company. The company is based in Newport Beach, CA. The CEO of the company is Diane Tang-Liu. | Finance |
- Borsa valori
- Insiders
- Jinn Wu
